title: Identification of the enzymatic active site of CD38 by site-directed mutagenesis.
abstract: CD38 is a ubiquitous protein originally identified as a lymphocyte antigen and recently also found to be a multifunctional enzyme participating in the synthesis and metabolism of two Ca(2+) messengers, cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate. It is homologous to Aplysia ADP-ribosyl cyclase, where the crystal structure has been determined. Residues of CD38 corresponding to those at the active site of the Aplysia cyclase were mutagenized. Changing Glu-226, which corresponded to the catalytic residue of the cyclase, to Asp, Asn, Gln, Leu, or Gly eliminated essentially all enzymatic activities of CD38, indicating it is most likely the catalytic residue. Photoaffinity labeling showed that E226G, nevertheless, retained substantial NAD binding activity. The secondary structures of these inactive mutants as measured by circular dichroism were essentially unperturbed as compared with the wild type. Other nearby residues were also investigated. The mutants D147V and E146L showed 7- and 19-fold reduction in NADase activity, respectively. The cADPR hydrolase activity of the two mutants was similarly reduced. Asp-155, on the other hand, was crucial for the GDP-ribosyl cyclase activity since its substitution with either Glu, Asn, or Gln stimulated the activity 3-15-fold, whereas other activities remained essentially unchanged. In addition to these acidic residues, two tryptophans were also important, since all enzyme activities of W125F, W125Y, W189G and W189Y were substantially reduced. This is consistent with the two tryptophans serving a substrate positioning function. A good correlation was observed when the NADase activity of all the mutants was plotted against the cADPR hydrolase activity. Homology modeling revealed all these critical residues are clustered in a pocket near the center of the CD38 molecule. The results indicate a strong structural homology between the active sites of CD38 and the Aplysia cyclase.
authors.affiliation: Departments of Pharmacology and Physiology, University of Minnesota, Minneapolis, Minnesota 55455, USA.
authors.forename: C
authors.initials: C
authors.lastname: Munshi
authors.forename: R
authors.initials: R
authors.lastname: Aarhus
authors.forename: R
authors.initials: R
authors.lastname: Graeff
authors.forename: T F
authors.initials: TF
authors.lastname: Walseth
authors.forename: D
authors.initials: D
authors.lastname: Levitt
authors.forename: H C
authors.initials: HC
authors.lastname: Lee
mesh_terms: D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D000345:Affinity Labels; D019943:Amino Acid Substitution; D000818:Animals; D015703:Antigens, CD / Q000737:chemistry / Q000378:metabolism; D000943:Antigens, Differentiation / Q000737:chemistry* / Q000378:metabolism*; D001048:Aplysia / Q000201:enzymology; D001224:Aspartic Acid; D001386:Azides / Q000493:pharmacokinetics; D001665:Binding Sites; D002942:Circular Dichroism; D003001:Cloning, Molecular; D018360:Crystallography, X-Ray; D006801:Humans; D007700:Kinetics; D008562:Membrane Glycoproteins; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D009243:NAD / Q000031:analogs & derivatives / Q000378:metabolism* / Q000493:pharmacokinetics; D009244:NAD+ Nucleosidase / Q000737:chemistry* / Q000378:metabolism*; D010843:Pichia; D017433:Protein Structure, Secondary; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism
chemical_list: D000345:Affinity Labels; D015703:Antigens, CD; D000943:Antigens, Differentiation; D001386:Azides; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D009243:NAD; C069931:nicotinamide 8-azidoadenine dinucleotide; D001224:Aspartic Acid; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1